Researchers warn against use of transfusions for trial eligibility

10/21/2010 | MedPage Today (free registration)

Canadian researchers have reported three cases involving patients who underwent blood transfusions in order to qualify as participants for trials of new cancer drugs. The researchers have expressed concern over the practice, citing the risks associated with transfusions, and are recommending that all other options -- such as using anemia treatments -- be exhausted first before resorting to blood transfusions.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID